Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Modulation of matrix metalloproteases by ciliary neurotrophic factor in human placental development

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Ciliary neurotrophic factor (CNTF) is a pleiotropic cytokine that signals through a receptor complex containing a specific subunit, CNTF receptor α (CNTFRα). The two molecules are constitutively expressed in key structures for human placental growth and differentiation. The possible role of CNTF in enhancing cell proliferation and/or invasion during placental development and remodelling was investigated using HTR-8/SVneo and BeWo cells, taken respectively as cytotrophoblast and syncytiotrophoblast models. In both cell lines, treatment with human recombinant (hr) CNTF activated JAK2/STAT3 signalling and inhibited the ERK pathway. Interestingly, in HTR-8/SVneo cells, 50 ng hrCNTF induced significant downregulation of matrix metalloprotease (MMP)-1 and significant upregulation of MMP-9. Moreover, pharmacological inhibition of JAK2/STAT3 signalling by AG490 and curcumin resulted in MMP-9 downregulation; it activated the ERK signalling pathway and upregulated MMP-1 expression. Collectively, these data suggest a role for CNTF signalling in extravillous cytotrophoblast invasion through the modulation of specific MMPs.

          Related collections

          Most cited references48

          • Record: found
          • Abstract: not found
          • Article: not found

          Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Structure and function of matrix metalloproteinases and TIMPs.

            Matrix metalloproteinases (MMPs), also called matrixins, function in the extracellular environment of cells and degrade both matrix and non-matrix proteins. They play central roles in morphogenesis, wound healing, tissue repair and remodelling in response to injury, e.g. after myocardial infarction, and in progression of diseases such as atheroma, arthritis, cancer and chronic tissue ulcers. They are multi-domain proteins and their activities are regulated by tissue inhibitors of metalloproteinases (TIMPs). This review introduces the members of the MMP family and discusses their domain structure and function, proenyme activation, the mechanism of inhibition by TIMPs and their significance in physiology and pathology.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Physiology and pathophysiology of matrix metalloproteases

              Matrix metalloproteases (MMPs) comprise a family of enzymes that cleave protein substrates based on a conserved mechanism involving activation of an active site-bound water molecule by a Zn2+ ion. Although the catalytic domain of MMPs is structurally highly similar, there are many differences with respect to substrate specificity, cellular and tissue localization, membrane binding and regulation that make this a very versatile family of enzymes with a multitude of physiological functions, many of which are still not fully understood. Essentially, all members of the MMP family have been linked to disease development, notably to cancer metastasis, chronic inflammation and the ensuing tissue damage as well as to neurological disorders. This has stimulated a flurry of studies into MMP inhibitors as therapeutic agents, as well as into measuring MMP levels as diagnostic or prognostic markers. As with most protein families, deciphering the function(s) of MMPs is difficult, as they can modify many proteins. Which of these reactions are physiologically or pathophysiologically relevant is often not clear, although studies on knockout animals, human genetic and epigenetic, as well as biochemical studies using natural or synthetic inhibitors have provided insight to a great extent. In this review, we will give an overview of 23 members of the human MMP family and describe functions, linkages to disease and structural and mechanistic features. MMPs can be grouped into soluble (including matrilysins) and membrane-anchored species. We adhere to the ‘MMP nomenclature’ and provide the reader with reference to the many, often diverse, names for this enzyme family in the introduction.
                Bookmark

                Author and article information

                Contributors
                a.giordano@staff.univpm.it
                d.marzioni@staff.univpm.it
                Journal
                Cell Tissue Res
                Cell Tissue Res
                Cell and Tissue Research
                Springer Berlin Heidelberg (Berlin/Heidelberg )
                0302-766X
                1432-0878
                7 July 2022
                7 July 2022
                2022
                : 390
                : 1
                : 113-129
                Affiliations
                [1 ]GRID grid.7010.6, ISNI 0000 0001 1017 3210, Department of Experimental and Clinical Medicine, , Università Politecnica Delle Marche, ; 60126 Ancona, Italy
                [2 ]GRID grid.411490.9, ISNI 0000 0004 1759 6306, Clinica Di Ostetricia E Ginecologia, , Azienda Ospedaliero Universitaria Ospedali Riuniti Di Ancona, ; 60123 Ancona, Italy
                [3 ]GRID grid.7010.6, ISNI 0000 0001 1017 3210, Department of Clinical and Molecular Sciences, , Università Politecnica Delle Marche, ; Ancona, Italy
                [4 ]GRID grid.415845.9, Hematology Unit, AUO Ospedali Riuniti Di Ancona, ; 60123 Ancona, Italy
                [5 ]GRID grid.452490.e, Department of Biomedical Science, , Humanitas University, ; Via Rita Levi Montalcini 4, 20090 Pieve Emanuele, Milan, Italy
                [6 ]GRID grid.417728.f, ISNI 0000 0004 1756 8807, Humanitas Clinical and Research Center-IRCCS, ; Via Manzoni56, 20089 Rozzano, Italy
                [7 ]GRID grid.7010.6, ISNI 0000 0001 1017 3210, Department of Clinical Sciences, , Università Politecnica Delle Marche, Salesi Hospital, ; 60123 Ancona, Italy
                [8 ]GRID grid.414603.4, U.O.C. Di Ostetricia E Patologia Ostetrica, Dipartimento Di Scienze Della Salute Della Donna, , Fondazione Policlinico Universitario A. Gemelli IRCCS, del Bambino E Di Sanità Pubblica, ; 00168 Rome, Italy
                [9 ]GRID grid.8142.f, ISNI 0000 0001 0941 3192, Istituto Di Clinica Ostetrica E Ginecologica, , Università Cattolica del Sacro Cuore, ; 00168 Rome, Italy
                Author information
                http://orcid.org/0000-0003-1273-3335
                http://orcid.org/0000-0002-2267-0270
                Article
                3658
                10.1007/s00441-022-03658-1
                9525382
                35794391
                da14fe77-f2d5-4928-9f51-3a883214c1c8
                © The Author(s) 2022

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 27 May 2021
                : 21 June 2022
                Funding
                Funded by: Italian Ministry of Health
                Award ID: Starting Grant 2018 (SG-2018-12367994)
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100005758, Università Politecnica delle Marche;
                Award ID: RSA 2018 - 2020
                Award Recipient :
                Funded by: Università Politecnica delle Marche
                Categories
                Regular Article
                Custom metadata
                © Springer-Verlag GmbH Germany, part of Springer Nature 2022

                Molecular medicine
                placenta,mmp,cntf,pstat3, perk
                Molecular medicine
                placenta, mmp, cntf, pstat3, perk

                Comments

                Comment on this article